These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34333834)

  • 1. The miRNAs involved in prostate cancer chemotherapy response as chemoresistance and chemosensitivity predictors.
    Konoshenko M; Laktionov P
    Andrology; 2022 Jan; 10(1):51-71. PubMed ID: 34333834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin.
    Konoshenko M; Lansukhay Y; Krasilnikov S; Laktionov P
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNAs and radical prostatectomy: Current data, bioinformatic analysis and utility as predictors of tumour relapse.
    Konoshenko MY; Laktionov PP
    Andrology; 2021 Jul; 9(4):1092-1107. PubMed ID: 33638886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer therapy outcome prediction: are miRNAs a suitable guide for therapeutic decisions?
    Konoshenko M; Laktionov P; Bryzgunova O
    Andrology; 2024 May; 12(4):705-718. PubMed ID: 37750354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs and radiotherapy response in prostate cancer.
    Konoshenko MY; Bryzgunova OE; Laktionov PP
    Andrology; 2021 Mar; 9(2):529-545. PubMed ID: 33053272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
    Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
    PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.
    Matuszcak C; Haier J; Hummel R; Lindner K
    World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
    Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA as Regulators of Prostate Carcinogenesis and Endocrine and Chemoresistance.
    Culig Z
    Curr Cancer Drug Targets; 2021; 21(4):283-288. PubMed ID: 33423646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-derived microRNAs contribute to prostate cancer chemoresistance.
    Li J; Yang X; Guan H; Mizokami A; Keller ET; Xu X; Liu X; Tan J; Hu L; Lu Y; Zhang J
    Int J Oncol; 2016 Aug; 49(2):838-46. PubMed ID: 27278879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway.
    Singh S; Chitkara D; Mehrazin R; Behrman SW; Wake RW; Mahato RI
    PLoS One; 2012; 7(6):e40021. PubMed ID: 22768203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs and androgen deprivation therapy for prostate cancer.
    Konoshenko MY; Bryzgunova OE; Laktionov PP
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188625. PubMed ID: 34534639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening candidate microRNA-mRNA network for predicting the response to chemoresistance in osteosarcoma by bioinformatics analysis.
    Dai P; He Y; Luo G; Deng J; Jiang N; Fang T; Li Y; Cheng Y
    J Cell Biochem; 2019 Oct; 120(10):16798-16810. PubMed ID: 31090103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-guided gene expression in prostate cancer: Literature and database overview.
    Bryzgunova OE; Konoshenko MY; Laktionov PP
    J Gene Med; 2018 May; 20(5):e3016. PubMed ID: 29578262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
    Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
    Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of microRNAs in Regulating Chemotherapy Resistance of Non-Small Cell Lung Cancer.
    Wei X; Shen X; Ren Y; Hu W
    Curr Pharm Des; 2018 Feb; 23(39):5983-5988. PubMed ID: 29046142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.
    Ma H; Wang LY; Yang RH; Zhou Y; Zhou P; Kong L
    J Cell Biochem; 2019 Oct; 120(10):17779-17790. PubMed ID: 31127646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs.
    Rizzo M
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188481. PubMed ID: 33217485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer.
    Zhu W; Shao Y; Peng Y
    Mol Carcinog; 2017 Jun; 56(6):1570-1577. PubMed ID: 28052414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.